Tonix Pharmaceuticals Holding Corp. (TNXP): Cash & Equivalents
$207.64M
As of 2025-12-31
$176.23M
As of 2026-06-30
+20.0%
3-year compound annual growth
+21.9%
5-year compound annual growth
+26.9%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $207.64M | +110.2% | 2026-03-12, Balance as of period end |
| 2024-12-31 | $98.78M | +295.9% | 2026-03-12, Balance as of period end |
| 2023-12-31 | $24.95M | -79.2% | 2025-03-18, Balance as of period end |
| 2022-12-31 | $120.23M | -32.7% | 2024-04-01, Balance as of period end |
| 2021-12-31 | $178.66M | +131.8% | 2023-03-13, Balance as of period end |
| 2020-12-31 | $77.07M | +585.1% | 2022-03-14, Balance as of period end |
| 2019-12-31 | $11.25M | -55.1% | 2021-03-15, Balance as of period end |
| 2018-12-31 | $25.03M | -1.8% | 2020-03-24, Balance as of period end |
| 2017-12-31 | $25.50M | +34.6% | 2019-03-18, Balance as of period end |
| 2016-12-31 | $18.94M | -1.2% | 2018-03-09, Balance as of period end |
| 2015-12-31 | $19.18M | -49.8% | 2017-04-13, Balance as of period end |
| 2014-12-31 | $38.18M | +365.5% | 2016-03-03, Balance as of period end |
| 2013-12-31 | $8.20M | n/a | 2016-03-03, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 2025-12-31 | $207.64M | +110.2% |
| Evommune, Inc. (EVMN) | 2025-12-31 | $44.06M | +171.1% |
| Emmaus Life Sciences, Inc. (EMMA) | 2025-12-31 | $2.13M | +53.1% |
| Pyxis Oncology, Inc. (PYXS) | 2025-12-31 | $15.42M | -20.8% |
| Arbutus Biopharma Corp (ABUS) | 2025-12-31 | $18.01M | -50.4% |
| Prelude Therapeutics Inc (PRLD) | 2025-12-31 | $35.26M | +182.6% |
| Opus Genetics, Inc. (IRD) | 2025-12-31 | $45.09M | +48.7% |
| Jaguar Health, Inc. (JAGX) | 2025-12-31 | $968.0K | -87.9% |
| Crescent Biopharma, Inc. (CBIO) | 2025-12-31 | $213.19M | +513.2% |
Compare TNXP, EVMN, EMMA, PYXS side by side · Screen every company in Pharmaceutical Preparations ↗